IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 136 filers reported holding IMMUNITYBIO INC in Q2 2022. The put-call ratio across all filers is 1.87 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3 | -25.0% | 1,610 | 0.0% | 0.00% | – |
| Q2 2023 | $4 | +33.3% | 1,610 | 0.0% | 0.00% | – |
| Q1 2023 | $3 | -62.5% | 1,610 | 0.0% | 0.00% | – |
| Q4 2022 | $8 | -99.9% | 1,610 | +8.6% | 0.00% | – |
| Q3 2022 | $7,000 | -92.6% | 1,483 | -94.2% | 0.00% | -100.0% |
| Q2 2022 | $95,000 | -24.6% | 25,589 | +14.1% | 0.00% | 0.0% |
| Q1 2022 | $126,000 | +31.2% | 22,432 | +42.4% | 0.00% | 0.0% |
| Q4 2021 | $96,000 | +68.4% | 15,756 | +170.7% | 0.00% | – |
| Q3 2021 | $57,000 | +418.2% | 5,820 | +680.2% | 0.00% | – |
| Q2 2021 | $11,000 | +120.0% | 746 | +245.4% | 0.00% | – |
| Q1 2021 | $5,000 | – | 216 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Winning Points Advisors, LLC | 251,556 | $1,387,000 | 1.70% |
| ORACLE INVESTMENT MANAGEMENT INC | 315,322 | $1,567,000 | 0.89% |
| HARBOURVEST PARTNERS LLC | 335,709 | $1,668,000 | 0.54% |
| ALLEN HOLDING INC /NY | 687,571 | $3,417,000 | 0.54% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $479,000 | 0.21% |
| SHEETS SMITH WEALTH MANAGEMENT | 207,926 | $1,033,000 | 0.17% |
| Clearwater Capital Advisors, LLC | 185,911 | $924,000 | 0.13% |
| WEALTH EFFECTS LLC | 28,500 | $142,000 | 0.09% |
| Virtus ETF Advisers LLC | 35,048 | $174,000 | 0.07% |
| Vident Investment Advisory, LLC | 195,127 | $969,000 | 0.03% |